A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
Novartis
Novartis
National Cancer Institute (NCI)
Novartis
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Baylor College of Medicine
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Medical College of Wisconsin
M.D. Anderson Cancer Center